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Abstract
Background: Toll-like receptors (TLR) and cytokines play a central role in the pathogen clearance as well as in pathological
processes. Recently, we reported that TLR2, TLR4 and TLR9 are differentially modulated in injured livers from BALB/c and
C57BL/6 (B6) mice during Trypanosoma cruzi infection. However, the molecular and cellular mechanisms involved in local
immune response remain unclear.
Methodology/Principal Findings: In this study, we demonstrate that hepatic leukocytes from infected B6 mice produced
higher amounts of pro-inflammatory cytokines than BALB/c mice, whereas IL10 and TGFb were only released by hepatic
leukocytes from BALB/c. Strikingly, a higher expression of TLR2 and TLR4 was observed in hepatocytes of infected BALB/c
mice. However, in infected B6 mice, the strong pro-inflammatory response was associated with a high and sustained
expression of TLR9 and iNOS in leukocytes and hepatic tissue respectively. Additionally, co-expression of gp91- and p47-
phox NADPH oxidase subunits were detected in liver tissue of infected B6 mice. Notably, the pre-treatment previous to
infection with Pam3CSK4, TLR2-agonist, induced a significant reduction of transaminase activity levels and inflammatory foci
number in livers of infected B6 mice. Moreover, lower pro-inflammatory cytokines and increased TGFb levels were detected
in purified hepatic leukocytes from TLR2-agonist pre-treated B6 mice.
Conclusions/Significance: Our results describe some of the main injurious signals involved in liver immune response during
the T. cruzi acute infection. Additionally we show that the administration of Pam3CSk4, previous to infection, can attenuate
the exacerbated inflammatory response of livers in B6 mice. These results could be useful to understand and design novel
immune strategies in controlling liver pathologies.
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Introduction
Accumulative evidences demonstrated that the liver has specific
immunological properties and contains a large number of resident
and non-resident cells that participate in the regulation of
inflammatory and immune responses [1,2].
Kupffer cells are among the first cells that orchestrate the
inflammatory response under many pathological conditions and they
produce pro-inflammatory cytokines and several chemokines after
pathogen stimulation. Interestingly, while TNFa and IL6 released by
Kupffer cells are involved in hepatic inflammation and liver cell
death, paradoxically they also mediate regeneration of the liver after
injury [1,3]. Importantly, hepatic infiltration of neutrophils partici-
pates in early response to cellular stress, and their activation is critical
for host defence but can also cause additional tissue damage. Thus,
proteases and reactive oxygen species (ROS) released by neutrophils
canresult inmitochondrialdysfunction and eventuallyinnecroticcell
death [4]. Hepatocytes are the most abundant cells in the liver, and it
has been shown that they have an important role not only in
detoxification but also in controlling systemic innate immunity via
production of secreted PRRs and complement components, while
also acting as antigen presenting cells [2,3]. Primary culture of
hepatocytes express mRNA for all TLRs and respond to TLR2 and
TLR4 ligands [1]. Recently, it has also been reported that
hepatocytes are desensitized by LPS in a TLR4 signalling-dependent
manner [5]. However, LPS response is mediated by several hepatic
cell populations, which are part of a cellular network involved in the
hepatic wound healing and regenerative response [1,6,7].
Although, the liver is the target of a wide range of microbes
including Listeria, Salmonella and Plasmodium species, there are few
www.plosntds.org 1 November 2010 | Volume 4 | Issue 11 | e863data related to the implication of Trypanosoma cruzi experimental
infection in liver and the relevance of the innate immune response
in this organ [8,9].
The T. cruzi parasite, an obligate intracellular protozoan, is the
causative agent of Chagas disease and represents an important
public health burden in Latin America. Nowadays, this infection
affects at 9 million people, and more than 30,000 new cases occur
every year (WHO; 2007. http://www.who.int/mediacentre/
news/notes/2007/np16/en/index.html). Chagas disease is char-
acterized by two distinct phases, the acute phase which lasts 2–4
months, involves a number of parasites detected in the blood
stream as well as in host tissues followed by a life-long chronic
phase. Parasite persistence eventually leads to severe complications
in cardiac and gastrointestinal tissue. However, T cruzi also infects
the reticuloendothelial system including the liver, spleen and bone
marrow. Hepatic affection during acute infection by T. cruzi has
been demonstrated both in humans and experimental animals
[10–12]. Despite extensive experimental investigations, the proper
mechanism developed by the host to limit acute T. cruzi infection
has not been fully elucidated. We have recently reported severe
hepatic injury in B6 mice infected with T. cruzi, Tulahue ´n strain.
The high mortality in B6 mice was associated with an unbalanced
pro-inflammatory cytokine profile, a decreased TLR2 and TLR4
and an increased TLR9 expression in the liver compared to
infected BALB/c mice [13]. In this study, we hypothesized that
the injurious and non-controlled local inflammatory response in
the liver depends on the adequate activation of immuno-
modulatories signalling, such as TLR2 and TGFb cytokine, on
both non-immune and immune liver cells during T. cruzi infection.
With the purpose to gain more knowledge about the mechanisms
involved in hepatic injury during T. cruzi infection, we analyzed
the ability of hepatic leukocytes to produce cytokines and
inflammatory mediators, such as NO and ROS, which could
directly and/or indirectly trigger tissue injury. In parallel, we also
investigated liver iNOS and nicotinamide adenine dinucleotide
phosphate (NAPDH) oxidase gp91 and p47 phox expression, the
main inducers of NO and ROS, respectively. In addition, we
evaluated the induction of TLR2, TLR4 and TLR9 in leukocytes
infiltrating the liver and hepatocytes during T. cruzi acute
infection. Taking into account that the use of TLR-agonists is a
potential therapeutic approach and a promissing strategy to treat
infectious diseases [14–16], we also evaluated if Pam3CSK4
(TLR2-TLR1 agonist) pre-treatment before challenge with T. cruzi
is able to modulate the strong liver inflammatory response elicited
in B6 mice. Our results show for the first time that, high and
sustained levels of NO, ROS and pro-inflammatory cytokines
would be dangerous signals to the liver during T, cruzi acute
infection. The administration of Pam3CSk4, previous to infection,
clearly attenuated the exacerbated inflammation in liver of B6
mice during acute T. cruzi infection, Tulahue ´n strain.
Materials and Methods
Mice, infection and parasitemia
BALB/c and B6 mice were purchased from the Faculty of
Veterinary Sciences (National University of La Plata, Bs As,
Argentina) and maintained according to the National Research
Council’s guide for the care and use of laboratory animals.
Protocols were approved by the Animals Experimentation Ethics
Committee, Faculty of Chemical Science, National University of
Cordoba. Six to eight week-old females of both mouse strains were
infected intraperitoneally with 5610
3 T. cruzi blood-derived
trypomastigotes, Tulahue ´n strain. Non-infected mice for each
strain were used as control. Parasites were maintained by serial
passages from mouse to mouse.
TLR-agonist pre-treatment
Six to eight week-old B6 mice were pre-treated 24hs before to
infection with 10 ug of Pam3CSK4. At the next day the mice were
intraperitoneally infected with 5000 parasites. In addition, non-
infected mice were challenged with the same doses of TLR2-ligand
and controlled along the acute phase, 24 days post infection (dpi).
The different groups consist of infected mice, pre-treated/infected
mice, pre-treated/non-infected mice and non-infected mice.
Transaminase activity
Plasma glutamic-oxaloacetic transaminase (GOT) and glutamic-
pyruvic transaminase (GPT) activities were measured as tissue
damage index, employing a commercial kit (Wiener Lab) and
performed according to appended protocol.
Immunofluoroscence
Liver specimens were fixed in 4% paraformaldehyde and
embedded in paraffin. Sections deparaffinized and rehydrated
were permeabilized, blocked using Fc block, and incubated with
primary antibody, rabbit polyclonal anti-TLR2 at 1/50, rabbit
polyclonal anti-p47-phox at 1/200, goat anti-mouse TLR4 at 1/
100, goat polyclonal anti-gp91at 1/400, or monoclonal anti-mouse
TLR9 1/100 dilutions (Santa Cruz Biotechnology) in PBS
containing 2% (w/v) BSA. After washing, the sections were
incubated with FITC-conjugated anti-rabbit (1/200), TRITC-
conjugated anti-goat (1/200), and FITC-conjugated anti-mouse
(1/100). Nuclei were examined using DNA-binding fluorochome
Hoechst 33258 (2 ug/ml). Slides were observed with a NIKON
ECLIPSE TE-2000 U Microscope equipped with UV and
fluorescence broadband.
Flow cytometry analysis of liver leukocytes
Hepatic leukocytes were isolated from both infected and non-
infected mouse strains as previously described [13]. Briefly, liver in
Author Summary
Trypanosoma cruzi, an obligate intracellular protozoan, is
the etiological agent of Chagas Disease that represents an
important public health burden in Latin America. The
infection with this parasite can lead to severe complica-
tions in cardiac, liver and gastrointestinal tissue depending
on the strain of parasite and host genetics. Recently, we
reported a fatal liver injury in T. cruzi infected B6 mice.
However, the local immune response against this parasite
is poorly understood. This work highlights some of the
molecular and cellular mechanisms involved in liver
pathology during the acute phase of infection. Using
two mouse strains with different genetic backgrounds and
responses to infection, B6 and BALB/c, we found that
infected B6 mice develop a strong pro-inflammatory
environment associated with high TLR9 expression.
Conversely, infected BALB/c mice showed a more balanced
inflammatory response in liver. Moreover, higher TLR2 and
TLR4 expression were found only in hepatocytes from
BALB/c. These data emphasize the importance of an
adequate integration of signalling between immune and
non-immune cells to define the outcome of infection. In
addition, the pre-treatment with TLR2-agonist reverts the
strong pro-inflammatory environment in T. cruzi infected
B6 mice. These results could be useful in the understand-
ing and design of novel immune strategies in controlling
liver pathologies.
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passed through 100-mm nylon meshes; red blood cells were
removed using lysis buffer (SIGMA) and finally hepatocytes were
separated from leukocytes using isotonic 37% Percoll gradient
(SIGMA). For flow cytometry, 1610
6 cells were stained using a
standard protocol and the following Abs were used: FITC-labeled
rat anti-mouse Ly-6G-Gr1 and F4/80 (eBioscience), FITC-labeled
hamster anti-mouse CD3e mAb (BD Pharmingen), PE-labeled rat
anti-mouse TLR2 and TLR4 and biotin anti-mouse TLR9 mAb
(eBioscience). Stained samples were acquired using the Ortho
Diagnostics System (Johnson and Johnson Company) flow
cytometer, and data were recorded and analyzed using FlowJo
software 5.7.2 (Tree Star, Inc.).
RT-PCR assays
RNA was isolated from 50 mg of hepatic tissue using TRIZOL
reagent (Invitrogen) as previously described [13]. The cDNA
obtained was amplified by PCR using specific primers for gp91
and p47-phox. As an endogenous control GAPDH primer was
used. Each primer pair was tested to reach the appropriate
condition of amplification. The primer sequence (sense and
antisense) from 59 to 39: gp91 (GAAGACTCTGTATGGA-
Figure 1. Cytokines produced by hepatic leukocytes from infected and control BALB/c and B6 mice. A–H) Purified leukocytes were
cultured for 72 hs, and IL6, TNFa, IL12, IL1b, TGFb, IL10, IFNc and IL4 were assayed in supernatants. Six animals per group were analyzed and data are
representative of one of three independent experiments. Statistical significance evaluated by Two-way ANOVA-Bonferroni’s post-hoc test is indicated
with a p-value ,0.05. (*) To compare infected vs control mice.
doi:10.1371/journal.pntd.0000863.g001
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www.plosntds.org 3 November 2010 | Volume 4 | Issue 11 | e863Figure 2. iNOS expression on hepatic tissue and nitrite production by liver leukocytes. Kinetics of gp91 and p47-phox NADPDH oxidase
expression in liver tissues from infected and control BALB/c and B6 mice. A) Liver iNOS expression at14, 21 and 24 dpi, analyzed by Western blot. Non-
infected control mice are indicated as ‘‘C’’. The square indicates an iNOS significant increase in infected compared to control B6 mice. B) Nitrites were
measured in supernatants of cultured hepatic leukocytes from infected (14 and 21dpi) and control mice. C) PCR products in agarose gel
electrophoresis and western blot assays for GAPDH, actin, gp91 and p47-phox. The square indicates a significant increase of p47-phox subunit at
24dpi in B6 compared to BALB/c. D) Immunofluorescence merge for gp91 and p47-phox in control and infected liver from BALB/c and B6 mice, at
24dpi, are shown. Six animals/group were analyzed and data are representative of one of three independent experiments. A p-value ,0.05 was
considered significant using Two-way ANOVA test. (*) To compare infected vs control mice in each mouse strain. (**) To compare B6 vs BALB/c mice.
doi:10.1371/journal.pntd.0000863.g002
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(GACCTGTCGGAGAAGGTGGT and CTTCACGGGCA-
GTCCCATGA) GAPDH (ACCACCATGGAGAAGGCCGG
and CTCAGTGTAGCCCAAGATGC).
Relative expression levels of the transcripts were estimated by
standardization with internal control of GAPDH gene, and evaluated
by densitometry using the GELPRO 3.1 analysis program.
Cytokine assays
Hepatic leukocytes (2610
6/ml) from infected (14 and 21dpi)
and non-infected mice (purified as described above) were cultured
with RPMI medium (Sigma) containing 10% FBS and 40 ug/ml
gentamycin for 72 h. ELISA assay was performed as previously
described [13] for IL1b, IL4, IL6, IL10, IL12, TGFb, TNFa and
IFNc cytokines. Standard curves were generated using recombi-
nant cytokine for each of them (eBioscience).
Nitrite determination
Supernatants (100 ml) were mixed with Griess reagent (Sigma,
USA) at a ratio of 1:1 and incubated at room temperature for
15 min. The absorbance was measured at 540 nm using a
microplate reader and nitrite concentration was calculated in
mM using a standard curve of sodium nitrite.
Western blot assays
Livers were washed and lysed for 30 min on ice in lysis buffer
(1% Triton X-100, 0.5% sodium deoxicholate, 9% SDS, 5%
dithiothreitol (DTT), 1 mM sodium ortovanadate, 10 ug PMSF,
30 ug aprotinin in PBS). Aliquots of tissue lysates, diluted in SDS
sample buffer, were separated on a 10% SDS-PAGE and western
blot assays were performed as previously described [13]. The
following antibodies were used: rabbit polyclonal anti-p47-phox
at 1/200 dilution or goat polyclonal anti-gp91 (Santa Cruz
Biotechnology) at 1/800 in PBS containing 1% (w/v) BSA. The
assays were revealed using the ECL chemiluminescent system
(Amersham Pharmacia Biotech) according to the manufacturer’s
instructions.
Statistical analysis
Statistical significance among groups was assessed by ANOVA.
To compare different experimental conditions an analysis of
variance (Two-way or one-way ANOVA) with Bonferroni’s post-
hoc test was performed. A p-value ,0.05 was considered
significant.
Results
Hepatic leukocytes from B6 mice showed an exacerbated
pro-inflammatory cytokine profile
During the acute phase of the inflammatory response, a variety
of pro-inflammatory cytokines are released which can induce
activation, danger or regenerative signalling.
The cytokine production was evaluated in supernatant of
purified hepatic leukocytes by ELISA. A strong inflammatory
profile, characterized by high levels of IL6, TNFa, IL12, and IL1b
was found in B6 mice at 14 and 21 dpi compared to control mice
(Figure 1A–D). BALB/c mice also showed an increase in IL6 and
IL12 levels, but only at 14dpi (Figure 1A and C). In addition,
TNFa and IL1b secretion by hepatic leukocytes from infected
BALB/c did not produce any changes compared to non-infected
mice (Figure 1B and D). The inflammatory response in liver was
similar to our previously reported results using splenic leukocytes
[13]. However and as opposed to spleen cells, purified liver
leukocytes from B6 did not produce IL10 and only induced a slight
increase in TGFb (Figure 1E and F). Interestingly, hepatic
leukocytes from infected BALB/c produced high levels of IL10
and TGFb, two important immunoregulatory cytokines at 14 and
21dpi (Figure 1E and F). On analyzing the polarizing cytokines,
we observed that T. cruzi infection induced a mixed Th1/Th2
profile with high levels of IFNc and moderated production of IL4
in BALB/c, whereas high levels of IFNc but not IL4 was detected
in infected B6 mice (Figure 1G and H). These results indicate that
T. cruzi acute infection induces a polarized Th1 profile in liver of
B6 mice.
Figure 3. Positive CD3, Gr1 and F4/80 hepatic leukocytes
expressing TLR2, TLR4 and TLR9. The TLR expression, after gating
on CD3, Gr1 and F4/80, are showed in A, B and C respectively. Absolute
numbers of double positive cells for CD3 (A), Gr1 (B) or F4/80 (C) and
TLR2, TLR4 or TLR9 are shown. (*) Statistical significant increase
comparing leukocytes from infected mice vs non-infected control mice
in each mouse strain. Arrowhead indicates statistical difference in TLR9
expression at 21dpi comparing BALB/c vs B6. These assays were
performed with six animals per group. Data are representative of one of
three independent experiments. A p-value ,0.05 was considered
significant using Two-way ANOVA test.
doi:10.1371/journal.pntd.0000863.g003
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expression in hepatic tissue and sustained NO
production were detected in B6 liver leukocytes
It is widely known that NO, which is produced by the enzyme
iNOS, is a key mediator of a variety of biological functions, such as
microbicidal activity and immunosuppression. However, NO is
also associated with the most important immunopathologies,
including septic shock [17,18]. Taking into account that NO
metabolite and Th1-biased response are involved in T. cruzi
induced myocarditis [19] we quantified the iNOS induction and
NO production as a possible mechanism involved in liver injury
during this infection. As shown in Figure 2A, an increased iNOS
expression was observed in hepatic tissue from B6 mice at 14dpi
by Western blot. However, tissue from infected BALB/c did not
reveal any changes in iNOS induction when compared to non-
infected mice (Figure 2A). Nitrite production was increased in
cultured hepatic leukocyte supernatants from both mouse strains
at 14 dpi, but this was significantly lower in BALB/c than in B6.
Additionally, B6 liver leukocytes showed a sustained nitrite
production up to 21dpi (Figure 2B).
NADPH oxidase is a highly regulated membrane-bound
enzyme complex found in a variety of phagocytic and non-
phagocytic cells. The core enzyme consists of five subunits: p40-/
p47-/p67-phox (cytosolic) and p22-/gp91-phox in plasma mem-
brane. Upon stimulation, the cytosolic subunit p47phox is
phosphorylated, and the entire cytosolic complex migrates to the
membrane, where it associates with p-22-/gp91 to form active
NADPH oxidase. Activation of NADPH oxidase leads to release of
ROS to the extracellular environment, or at intracellular
membranes. ROS production is important for killing pathogens,
but an over production may be also detrimental to tissue
homeostasis. In this work, we comparatively analyzed the
induction of gp91 and p47-phox, two major components of the
NADPH oxidase. The hepatic tissue from both mouse strains
showed a significant increase in gp91 and p47-phox mRNA and
proteins at 14, 21 and 24dpi compared to non-infected control
Figure 4. Cellular distribution of TLR2, TLR4 and TLR9 in hepatic tissue from infected (21 dpi) and control BALB/c and B6 mice. (A)
Liver sections were co-stained with TLR2 or TLR4 or TLR9 (red) and cytokeratin (green) to show the co-localization between TLR/parenchyma cells.
Nuclei were stained with Hoescht B) Intensity of TLR and cytokeratin merge was measured by LSM image examiner and representative values are
shown. The bars represent the means and standard deviations of the co-localized mark intensity of 4 fields per group. The arrows indicate hepatocyte
nuclei. Data are representative of one of three independent experiments. (*) Statistical significance compared to control levels is indicated (p-values
,0,05).
doi:10.1371/journal.pntd.0000863.g004
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sion was higher in B6 than in BALB/c at 24dpi (Figure 2C).
Supporting this result, the activation of NADPH oxidase complex
that involve co-localization in the plasma membrane of g91 and
p47-phox subunits was observed only in infected B6 at 24dpi
(Figure 2D).
Different TLR2, TLR4 and TLR9 modulation in hepatic
leukocytes and hepatocytes from BALB/c and B6 mice
were induced
Normal and injured livers are enriched in innate immune cells,
which have a significant impact on hepatic health or disease.
Recently, we demonstrated that during T. cruzi acute infection the
predominant leukocytes in liver were Gr1, F4/80 and CD3
positive cells [13]. These three populations accounted for more
than 80% of the infiltrated liver cells from both infected BALB/c
and B6 mouse strains.
In the present work, we analyzed the TLR2, TLR4 and TLR9
k i n e t i ce x p r e s s i o ni nC D 3 + (Figure 3A), Gr1+ (Figure 3B) and
F4/80+ (Figure 3C) hepatic leukocytes through double marking
and employing flow cytometry. We observed that the absolute
number for each double positive cell population expressing TLR2
and TLR4 was increased in both mouse strains at 14 and 21dpi
compared to non-infected control mice. However, this increase
did not show significant differences between both infected mouse
strains (Figure 3A–C). Interestingly, double positive cells for
TLR9 in CD3, Gr1 and F4/80 leukocytes were increased up to
21dpi only in infected B6 mice (Arrowhead in Figure 3A–C).
Previously, we reported a decrease of TLR2 and TLR4 and an
up-regulation of TLR9 in liver tissue of infected B6 mice, whereas
BALB/c showed higher expression of TLR2 and TLR4 and a
lower expression of TLR9 at the end of the acute phase [13].
Therefore, we think that other liver cells would be involved in the
TLR2 and TLR4 differential expression observed between these
mouse strains. Interestingly, the immunofluorescent analysis of
TLR2, TLR4 and TLR9 expression showed higher TLR2 and
TLR4 expression in hepatocytes from infected BALB/c com-
pared to infected B6 mice (Figure 4A–B). These results clearly
show a marked difference in the expression of TLR2 and TLR4
in hepatocytes from BALB/c and B6 during T. cruzi acute
infection.
Pre-treatment of B6 mice with TLR2 agonist before the
infection reduced the local inflammation and liver
damage during acute T. cruzi infection
Taking into account that the TLR2 upregulation in hepatic
tissue of infected BALB/c mice could be contributing to an anti-
inflammatory effect and that TLR2 has been proposed as an
immunomodulator receptor during T.cruzi infection [20], we
evaluated whether pre-treatment with Pam3CSK4, a TLR2-
TLR1 agonist, 24hs before infection with T. cruzi is able to
improve the immune response balance and the outcome of the
acute infection in B6 mice. Interestingly, the treatment of B6 mice
with TLR2 agonist significantly reduced the GOT/GPT ratio
compared to infected mice alone (Figure 5A). This result was very
exciting because it indicates a marked diminution of liver damage
during acute infection. Furthermore, the number of inflammatory
foci (Figure 5B) and the mortality (Table 1) in mice pre-treated
with TLR2 agonist were significantly lower than infected B6 mice
and not treated mice. This result was correlated with lower
transaminase activities (Pearson coefficient, r=0.9) and conse-
quently with a decreased tissue injury.
Hepatic leukocytes from Pam3CSK4 pre-treated B6 mice
showed less pro-inflammatory cytokine and NO
production
Testing the hypothesis that pre-treatment with Pam3CKS4
before T. cruzi infection would modulate the exacerbated
inflammatory response in B6 mice, we demonstrate a reduction
of IL6, IL12, TNFa and IL1b levels in pre-treated infected B6
mice compared to controls of infected mice alone (Figure 6A–D).
In parallel, an increase of TGFb concentration was detected in
mice treated with TLR2 agonist (Figure 6E). Notably, NO
secretion was also reduced in mice pre-treated compared to
infected mice alone at 14dpi (Figure 6G).
Our results suggest that the pre- treatment with Pam3CSK4
one day before infection reduces the inflammatory environment
and the hepatic damage of B6 mice during T. cruzi infection.
Figure 5. Plasma transaminase activity and inflammatory foci
number in TLR-ligand pre-treated B6 mice. The mice were pre-
stimulated 24hs before infection, with 10 ug of Pam3CSK4. A) Plasma
samples from infected and non-infected mice were collected at the
same time 14, 21 and 24dpi. GOT and GPT transaminase were measured
at indicate times and GOT/GPT ratios are indicated. B) Inflammatory foci
numbers were counted in 150 fields per liver section from different
groups of treated B6 mice at 24 dpi. Average and standard deviation of
four mice per group are shown. (*) Statistical significant (p-values ,0,05
calculated by Two-way ANOVA test) are indicated and the results
represent one of three independent experiments.
doi:10.1371/journal.pntd.0000863.g005
Table 1. Mortality percentage in pre-treated without
infection, pre-treated and infected, and infected B6 mice.
Pam3CSK4
Pam3CSK4+T.
cruzi T. cruzi
Mortality
percentage at
24dpi
0 42,28+/217.12 69,06+/215,16
doi:10.1371/journal.pntd.0000863.t001
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In the present work, we focus on the study of local immune
response in hepatic tissue during T. cruzi infection. Our results
clearly demonstrate that liver leukocytes from infected B6 mice
produce increased and persistent levels of TNFa, IL6, IL12 and
IL1b pro-inflammatory cytokines, associated with undetectable or
low IL10 and TGFb production. Previously, we observed a
enhanced apoptosis and necrosis in liver of this mouse strain [13].
Recently, it was reported that anti-TNFa treatment decreases
hepatic apoptosis of C57BL/6 mice infected with trypomastigotes
of Tulahue ´n strain, providing evidence about the role of this
cytokine in the induction of liver injury [12]. By contrast, in livers
from BALB/c mice, the pro-inflammatory profile was effectively
countered by IL10 and TGFb regulatory cytokines. In this mouse
strain, infection induced a mixed Th1/Th2 phenotype while a
dominant Th1 profile was observed in livers of infected B6 mice.
The Th1 response contributes to an effective parasite clearance
although an excessive inflammation may be deleterious for the
host. We postulated that a mixed cytokine prototype in BALB/c
might be insufficient for controlling parasite but might favour
tissue repair. Similarly, a mixed Th1/Th2 and a dominant Th1
phenotype was observed in heart of infected BALB/c and B6 mice
respectively [21].
Nitric oxide and ROS are two key inflammatory mediators
involved not only in pathogen clearance but also in tissue injury.
Nitric oxide is produced by different isoforms of NO synthase,
among them the inducible isoform (iNOS) that is activated by
Figure 6. Cytokines and NO production by hepatic leukocytes from TLR-ligand pre-treated B6 mice. Purified liver leukocytes were
obtained from each differently treated mice groups at 14 and 21dpi and cultured by 72hs. Supernatants were harvested and IL6 (A), IL12 (B), TNFa (C),
IL1b (D), TGFb (E) and IL10 (F) cytokines were determined by ELISA and NO (G) by Griess reaction. Four animals per group were analyzed and data are
representative of one of three independent experiments. Arrowhead indicates statistical significant reduction (p,0,05) in pre-treatment infected
mice compared to infected mice. (*) To indicate increase of TGFb in pre-treated/infected vs infected B6 mice.
doi:10.1371/journal.pntd.0000863.g006
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model. Hemodynamic instabilities and tissue damage caused by
NO may be related to different NO synthase isoforms [23] as well
as to differences in cellular concentration and/or temporal
expression [17,24]. In our work, we demonstrated a stronger
expression of hepatic iNOS and a higher NO production by liver
leukocytes of infected B6 compared to BALB/c mice. Interesting-
ly, this process was concomitant with high levels of pro-
inflammatory cytokines detected in B6 mice.
On the other hand, results presented here demonstrate that p47
and gp91-phox components of NADPH oxidase were increased in
livers of both infected mouse strains compared to non-infected.
However, an enhanced and sustained p47-phox expression was
observed in livers from B6 mice. Strikingly, the co-expression of
gp91 and p47-phox on the plasma membrane was found only in
liver from infected B6 at 24dpi. Several authors have described
that ROS can induce cell death by either apoptosis or necrosis in
liver pathologies [25,26]. Thus, the activation of NADPH oxidase
enzymatic complex would be a key player in the liver damage,
probably as an instrument contributing to liver apoptosis and
necrosis during infection in B6 mice.
TLRs have been shown to be critical for the protection against
infections. Recently, Padilla et al. 2009, demonstrated that
insufficient TLR activation contributes to the slow development
of CD8+ T cell responses in T. cruzi infection [16]. However, the
breakdown of homeostasis by infection can deregulate certain
pathways, such as TLR-cytokines, and plays a key role in the
pathogenesis of the liver disease. Our results show a similar TLR2
and TLR4 expression on hepatic macrophages, granulocytes and
T cells of infected BALB/c and B6 mice. However, the TLR9
expression showed a clear difference in hepatic leukocytes from
infected B6 and BALB/c mice. We found that only leukocytes
from infected B6 mice maintained high expression of TLR9
during the acute phase. These results support the hypothesis that
sustained TLR9 signalling might contribute to excessive and
harmful inflammatory response in infected B6 mice. In accordance
with our results, a crucial role of TLR9 in IL12 and IFNc
production during T. cruzi infection was recently shown [15],[27].
Furthermore, it is noteworthy that uninfected BALB/c and B6
mice did not show differences in their TLR9 expression, yet the
persistent levels of this receptor in infected B6 could involve some
lost factors, that are present in BALB/c, which should modulate
the excessive inflammatory response in liver. Interestingly, we
found that TLR2 and TLR4 are differentially modulated in
hepatocytes of infected BALB/c and B6 mice, suggesting that
these innate immune receptors would play a role not only in
immune cells but also in liver parenchyma cells. In this sense, it has
been postulated that TLR signalling in parenchyma cells would be
a key mechanism to prevent death caused by excessive cytokine
release [28–30]. There are increased evidences demonstrating the
potential role of TLR-ligands treatment as therapeutic approach
and they have shown to be highly effective in the protection
against protozoan, among them T. cruzi [15,31,32]. In our study
we observed that pre-treatment with Pam3CSK4, a TLR2-TLR1
agonist, before infection induced a marked reduction of pro-
inflammatory cytokines, nitrite and transaminasa levels and a
decrease in the number of hepatic inflammatory foci and
consequently in the mortality of infected mice.
Together these results suggest that TLRs and probably others
PRR should contribute to the induction of anti-parasite immune
response, but an altered TLR regulation could lead to tissue
damage. Interestingly, TLRs sense the endogenous molecules
released by dying cells and lead to fast IL1b release through
inflammasome activation [33]. Notably, in our model the IL-1b
cytokine was up regulated in infected B6 mice and it would be a
very interesting idea to explore activation of inflammasome
platform during acute phase of T. cruzi infection.
In our study we postulated that the inadequate integration of
signals involving molecular (TLRs, cytokines, NO and ROS) and
cellular (immune and parenchyma cells) components influences
the outcome of local immune response during this parasite
infection. Moreover, the differential TLR and cytokine modula-
tion in the liver, induced by T. cruzi infection, emphasize the
importance of local innate immune response in hosts with different
genetic background and could contribute to the understanding
and design of novel immune strategies in controlling liver
pathologies.
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